Operating Income (Loss) in USD of NEOGENOMICS INC from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Neogenomics Inc quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • Neogenomics Inc Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$27M, a 27.4% decline year-over-year.
  • Neogenomics Inc Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$121M, a 31% decline year-over-year.
  • Neogenomics Inc annual Operating Income (Loss) for 2024 was -$92.1M, a 14.5% increase from 2023.
  • Neogenomics Inc annual Operating Income (Loss) for 2023 was -$108M, a 31.7% increase from 2022.
  • Neogenomics Inc annual Operating Income (Loss) for 2022 was -$158M, a 32.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

NEOGENOMICS INC Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$121M -$27M -$5.82M -27.4% 01 Jul 2025 30 Sep 2025 10-Q 28 Oct 2025
Q2 2025 -$115M -$47.6M -$25.7M -117% 01 Apr 2025 30 Jun 2025 10-Q 29 Jul 2025
Q1 2025 -$89.4M -$27.8M +$2.74M +8.97% 01 Jan 2025 31 Mar 2025 10-Q 29 Apr 2025
Q4 2024 -$92.1M -$18.4M +$173K +0.93% 01 Oct 2024 31 Dec 2024 10-K 18 Feb 2025
Q3 2024 -$92.3M -$21.2M +$3M +12.4% 01 Jul 2024 30 Sep 2024 10-Q 28 Oct 2025
Q2 2024 -$95.3M -$21.9M +$7.95M +26.6% 01 Apr 2024 30 Jun 2024 10-Q 29 Jul 2025
Q1 2024 -$103M -$30.6M +$4.51M +12.8% 01 Jan 2024 31 Mar 2024 10-Q 29 Apr 2025
Q4 2023 -$108M -$18.6M +$7.81M +29.6% 01 Oct 2023 31 Dec 2023 10-K 18 Feb 2025
Q3 2023 -$116M -$24.2M +$15.3M +38.8% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024
Q2 2023 -$131M -$29.9M +$9.81M +24.7% 01 Apr 2023 30 Jun 2023 10-Q 30 Jul 2024
Q1 2023 -$141M -$35.1M +$17M +32.6% 01 Jan 2023 31 Mar 2023 10-Q 30 Apr 2024
Q4 2022 -$158M -$26.4M +$15.2M +36.5% 01 Oct 2022 31 Dec 2022 10-K 18 Feb 2025
Q3 2022 -$173M -$39.5M +$203K +0.51% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023
Q2 2022 -$173M -$39.7M -$17.3M -77.5% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 -$156M -$52M -$36.9M -244% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 -$119M -$41.6M -$47.1M -850% 01 Oct 2021 31 Dec 2021 10-K 20 Feb 2024
Q3 2021 -$71.6M -$39.7M -$44.4M -951% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 -$27.3M -$22.4M -$3.46M -18.3% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 -$23.8M -$15.1M -$9.81M -185% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 -$14M $5.54M +$3.22M +139% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2023
Q3 2020 -$17.2M $4.67M +$1.01M +27.6% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 -$18.2M -$18.9M -$23.4M -522% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 $5.17M -$5.29M -$7.84M -308% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 $13M $2.32M -$500K -17.7% 01 Oct 2019 31 Dec 2019 10-K 25 Feb 2022
Q3 2019 $13.5M $3.66M -$261K -6.66% 01 Jul 2019 30 Sep 2019 10-Q 29 Oct 2020
Q2 2019 $13.8M $4.48M +$3.68M +464% 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020
Q1 2019 $10.1M $2.55M +$43K +1.72% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020
Q4 2018 $10M $2.82M -$884K -23.9% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021
Q3 2018 $10.9M $3.92M +$5.98M 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 $4.94M $794K -$1.05M -56.9% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019
Q1 2018 $5.99M $2.51M +$3.09M 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019
Q4 2017 $2.9M $3.71M +$7.06M 01 Oct 2017 31 Dec 2017 10-K 28 Feb 2020
Q3 2017 -$4.16M -$2.06M -$3.46M -248% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018
Q2 2017 -$699K $1.84M -$352K -16.1% 01 Apr 2017 30 Jun 2017 10-Q 06 Aug 2018
Q1 2017 -$347K -$580K -$2.5M -130% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018
Q4 2016 $2.16M -$3.36M +$1.86M +35.7% 01 Oct 2016 31 Dec 2016 10-K 26 Feb 2019
Q3 2016 $294K $1.4M +$1.28M +1124% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017
Q2 2016 -$987K $2.19M +$2.17M +7732% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017
Q1 2016 -$3.15M $1.92M +$2.48M 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017
Q4 2015 -$5.64M -$5.22M -$6.54M -495% 01 Oct 2015 31 Dec 2015 10-K 13 Mar 2018
Q3 2015 $900K $114K +$187K 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016
Q2 2015 $713K $28K -$550K -95.2% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016
Q1 2015 $1.26M -$561K -$955K -242% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q4 2014 $2.22M $1.32M +$115K +9.55% 01 Oct 2014 31 Dec 2014 10-K 14 Mar 2017
Q3 2014 $2.1M -$73K -$1.23M -106% 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015
Q2 2014 $3.34M $578K +$73K +14.5% 01 Apr 2014 30 Jun 2014 10-Q 31 Jul 2015
Q1 2014 $3.26M $394K +$89K +29.2% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 $3.17M $1.2M +$1.01M +517% 01 Oct 2013 31 Dec 2013 10-K 18 Apr 2016
Q3 2013 $2.17M $1.16M +$1.84M 01 Jul 2013 30 Sep 2013 10-Q 04 Nov 2014
Q2 2013 $321K $505K -$334K -39.8% 01 Apr 2013 30 Jun 2013 10-Q 29 Jul 2014
Q1 2013 $655K $305K -$556K -64.6% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q4 2012 $1.21M $195K -$179K -47.9% 01 Oct 2012 31 Dec 2012 10-K 03 Mar 2015
Q3 2012 $1.39M -$684K -$726K -1729% 01 Jul 2012 30 Sep 2012 10-Q 30 Oct 2013
Q2 2012 $2.12M $839K +$953K 01 Apr 2012 30 Jun 2012 10-Q 02 Aug 2013
Q1 2012 $1.16M $861K +$1.57M 01 Jan 2012 31 Mar 2012 10-Q 13 May 2013
Q4 2011 -$409K $374K 01 Oct 2011 31 Dec 2011 10-K 24 Feb 2014
Q3 2011 $42K +$1.05M 01 Jul 2011 30 Sep 2011 10-Q 05 Nov 2012
Q2 2011 -$114K +$683K +85.7% 01 Apr 2011 30 Jun 2011 10-Q/A 15 Aug 2012
Q1 2011 -$711K 01 Jan 2011 31 Mar 2011 10-Q 14 May 2012
Q3 2010 -$1.01M 01 Jul 2010 30 Sep 2010 10-Q 25 Oct 2011
Q2 2010 -$797K 01 Apr 2010 30 Jun 2010 10-Q/A 01 Aug 2011

NEOGENOMICS INC Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$92.1M +$15.6M +14.5% 01 Jan 2024 31 Dec 2024 10-K 18 Feb 2025
2023 -$108M +$49.9M +31.7% 01 Jan 2023 31 Dec 2023 10-K 18 Feb 2025
2022 -$158M -$38.9M -32.7% 01 Jan 2022 31 Dec 2022 10-K 18 Feb 2025
2021 -$119M -$105M -749% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024
2020 -$14M -$27M -208% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2023
2019 $13M +$2.97M +29.5% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022
2018 $10M +$7.14M +246% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021
2017 $2.9M +$747K +34.7% 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2020
2016 $2.16M +$7.79M 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019
2015 -$5.64M -$7.85M -354% 01 Jan 2015 31 Dec 2015 10-K 13 Mar 2018
2014 $2.22M -$956K -30.1% 01 Jan 2014 31 Dec 2014 10-K 14 Mar 2017
2013 $3.17M +$1.96M +162% 01 Jan 2013 31 Dec 2013 10-K 18 Apr 2016
2012 $1.21M +$1.62M 01 Jan 2012 31 Dec 2012 10-K 03 Mar 2015
2011 -$409K +$2.55M +86.2% 01 Jan 2011 31 Dec 2011 10-K 24 Feb 2014
2010 -$2.96M 01 Jan 2010 31 Dec 2010 10-K 12 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.